Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 50090-4307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904307)

FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
This is a chart/table comparing two medications, oxybutynin and oxyhutynin, with their recommended dosages (10mg QD and 5mg TID) over time. No further context is available.*
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

FDA Label Image

Chemical Structure (Oxybutynin Struc)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.